Provided by Tiger Trade Technology Pte. Ltd.

TransMedics Group, Inc.

81.07
+0.79000.98%
Post-market: 82.411.34+1.65%16:53 EDT
Volume:962.42K
Turnover:79.09M
Market Cap:2.80B
PE:20.18
High:83.90
Open:80.96
Low:80.56
Close:80.28
52wk High:156.00
52wk Low:60.11
Shares:34.54M
Float Shares:33.28M
Volume Ratio:1.14
T/O Rate:2.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):4.02
EPS(LYR):4.87
ROE:36.28%
ROA:4.33%
PB:5.41
PE(LYR):16.65

Loading ...

TransMedics initiated with an Overweight at Barclays

TIPRANKS
·
Yesterday

Analysts Have Conflicting Sentiments on These Healthcare Companies: TransMedics Group (TMDX), Regeneron (REGN) and Tarsus Pharmaceuticals (TARS)

TIPRANKS
·
Oct 02

TransMedics Group (TMDX), Why Is It Back In The Spotlight?

Simply Wall St.
·
Oct 01

TransMedics Files Initial Beneficial Ownership Statement for CFO, Treasurer Fernando N. Araujo

Reuters
·
Sep 30

Canaccord Genuity Keeps Their Buy Rating on TransMedics Group (TMDX)

TIPRANKS
·
Sep 11

TransMedics Names Fernando Araujo CFO, Effective Sept. 21

Reuters
·
Sep 11

TransMedics Appoints Fernando Araujo as Chief Financial Officer and Reiterates 2026 Financial Outlook

Reuters
·
Sep 11

GUIDANCE: (TMDX) TransMedics Expects Full Year 2026 Revenue Range $737M - $757M, vs. FactSet Est of $743.1M

MT Newswires Live
·
Sep 11

TransMedics Reiterates 2026 Revenue Outlook of $737 Million-$757 Million

Reuters
·
Sep 11

Transmedics Group, - Gerardo Hernandez to Transition to Commercial Strategic Advisor, Latam

THOMSON REUTERS
·
Sep 11

Transmedics Appoints Fernando Araujo as Chief Financial Officer and Reiterates 2026 Financial Outlook

THOMSON REUTERS
·
Sep 11

TransMedics to Present at Morgan Stanley Global Healthcare Conference Fireside Chat

Reuters
·
Sep 01

TransMedics (TMDX) Stock Looks Below Fair Value Though Governance Risks Weigh

Simply Wall St.
·
Aug 26

Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), Spyre Therapeutics (SYRE) and COMPASS Pathways (CMPS)

TIPRANKS
·
Aug 13

TransMedics Rilis Presentasi Soal Teknologi Perfusi Organ Portabel Dan Jaringan Layanan-Logistik Transplantasi Nasional

Reuters
·
Aug 12

TransMedics Group Price Target Cut to $100.00/Share from $120.00 by Piper Sandler

Dow Jones
·
Aug 06

UBS Adjusts Price Target on TransMedics Group to $77 From $80, Maintains Neutral Rating

MT Newswires Live
·
Aug 05

TransMedics price target lowered to $95 from $124 at Canaccord

TIPRANKS
·
Aug 05

Transmedics Group, Inc. : Canaccord Genuity Cuts Target Price to $95 from $124

THOMSON REUTERS
·
Aug 05

Analysts Offer Insights on Healthcare Companies: IDEAYA Biosciences (IDYA) and TransMedics Group (TMDX)

TIPRANKS
·
Aug 05